It's a bullish beginning to the week for this industrials stalwart.

GE HealthCare Technologies’ blended fair value estimate has shifted only slightly, from about US$93.05 to US$93.47 per share, signaling a very small adjustment to where analysts see the stock’s price ...

When it comes to GE Vernova stock, investors believe. Boy, do they. JPMorgan believes so much that it raised its price target to $1,000. Wall Street success, of course, is a little different from ...

Morgan Stanley raised its price target on GE Vernova to $960 from $817 citing improving demand for gas turbines, rising ...

The average one-year price target for GE Vernova (NYSE:GEV) has been revised to $765.71 / share. This is an increase of 11.41% from the prior estimate of $687.26 dated December 3, 2025. The price ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

When it comes to GE Vernova stock, investors believe. Boy, do they. J.P. Morgan believes so much that it raised its price target to $1,000.